U. Testa, G. Castelli, and E. Pelosi, Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells, Cancers (Basel, vol.10, p.248, 2018.

G. Gaudino, J. Xue, and H. Yang, How asbestos and other fibers cause mesothelioma, Transl. Lung Cancer Res, vol.2020, pp.39-46

S. Roodhouse-gloyne, Two cases of squamous carcinoma of the lung occurring in asbestosis, Tubercle, vol.17, pp.5-10, 1935.

A. Pritchard, S. Tousif, Y. Wang, K. Hough, S. Khan et al., Lung Tumor Cell-Derived Exosomes Promote M2 Macrophage Polarization, Cells, vol.2020, 1303.

C. Hu, S. Meiners, C. Lukas, G. T. Stathopoulos, and J. Chen, Role of exosomal microRNAs in lung cancer biology and clinical applications, Cell Prolif, 2020.

V. Vignard, M. Labbé, N. Marec, G. André-grégoire, N. Jouand et al., MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma, Cancer Immunol. Res, 2019.
URL : https://hal.archives-ouvertes.fr/inserm-02426329

R. C. Friedman, K. K. Farh, C. B. Burge, and D. P. Bartel, Most mammalian mRNAs are conserved targets of microRNAs, Genome Res, vol.19, pp.92-105, 2009.

M. Colombo, G. Raposo, and C. Thery, Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles, Annu. Rev. Cell Dev. Biol, vol.30, pp.255-289, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02452769

D. Perez-hernandez, C. Gutiérrez-vázquez, I. Jorge, S. López-martín, A. Ursa et al., The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes, J. Biol. Chem, vol.288, pp.11649-11661, 2013.

H. Pollet, L. Conrard, A. Cloos, and D. Tyteca, Plasma membrane lipid domains as platforms for vesicle biogenesis and shedding?, vol.8, p.94, 2018.

K. Trajkovic, C. Hsu, S. Chiantia, L. Rajendran, D. Wenzel et al., Ceramide triggers budding of exosome vesicles into multivesicular endosomes, Science, vol.319, pp.1244-1247, 2008.

P. Stahl, G. Raposo, R. Palmulli, and G. Van-niel, To be or not to be secreted as exosomes, a balance finely tuned by the mechanisms of biogenesis, Essays Biochem, vol.62, pp.177-191, 2018.

K. J. Mckelvey, K. L. Powell, A. W. Ashton, J. M. Morris, and S. A. Mccracken, Exosomes: Mechanisms of Uptake, J. Circ. Biomark, vol.4, issue.7, 2015.

D. M. Pegtel, K. Cosmopoulos, D. A. Thorley-lawson, M. A. Van-eijndhoven, E. S. Hopmans et al., Functional delivery of viral miRNAs via exosomes, Proc. Natl. Acad. Sci, vol.107, pp.6328-6333, 2010.

S. Keerthikumar, D. Chisanga, D. Ariyaratne, H. Saffar, S. Anand et al., ExoCarta: A Web-Based Compendium of Exosomal Cargo, J. Mol. Biol, vol.428, pp.688-692, 2016.

H. Kalra, R. J. Simpson, H. Ji, E. Aikawa, P. Altevogt et al., A compendium for extracellular vesicles with continuous community annotation, vol.10, 2012.

D. Kim, J. Lee, R. J. Simpson, J. Lötvall, Y. S. Gho et al., A community web resource for prokaryotic and eukaryotic extracellular vesicles research, Semin. Cell Dev. Biol, vol.40, pp.4-7, 2015.

M. Record, K. Carayon, and M. Poirot, Silvente-Poirot, S. Exosomes as new vesicular lipid transporters involved in cell-cell communication and various pathophysiologies, Biochim. Biophys. Acta, vol.1841, pp.108-120, 2014.

K. Laulagnier, D. Grand, A. Dujardin, S. Hamdi, H. Vincent-schneider et al., PLD2 is enriched on exosomes and its activity is correlated to the release of exosomes, FEBS Lett, vol.572, pp.11-14, 2004.

C. Théry, K. W. Witwer, E. Aikawa, M. J. Alcaraz, J. D. Anderson et al., Minimal information for studies of extracellular vesicles 2018 (MISEV2018): A position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines, J. Extracell, vol.7, 2018.

N. Kosaka, H. Iguchi, K. Hagiwara, Y. Yoshioka, F. Takeshita et al., Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis, J. Biol. Chem, vol.288, pp.10849-10859, 2013.

C. Villarroya-beltri, C. Gutierrez-vazquez, F. Sanchez-cabo, D. Perez-hernandez, J. Vazquez et al., Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs, Nat. Commun, 2013.

L. Santangelo, G. Giurato, C. Cicchini, C. Montaldo, C. Mancone et al., The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting, Cell Rep, vol.17, pp.799-808, 2016.

M. J. Shurtleff, M. M. Temoche-diaz, K. V. Karfilis, S. Ri, and R. Schekman, Y-box protein 1 is required to sort microRNAs into exosomes in cells and in a cell-free reaction, vol.5, 2016.

D. Koppers-lalic, M. Hackenberg, I. V. Bijnsdorp, M. A. Van-eijndhoven, P. Sadek et al., Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes, Cell Rep, vol.8, pp.1649-1658, 2014.

J. Guduric-fuchs, A. O'connor, B. Camp, C. L. O'neill, R. J. Medina et al., Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types, BMC Genom, vol.13, 2012.

A. Sica, T. Schioppa, A. Mantovani, and P. Allavena, Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy, Eur. J. Cancer, vol.42, pp.717-727, 2006.

L. Cassetta and T. Kitamura, Macrophage targeting: Opening new possibilities for cancer immunotherapy, Immunology, vol.155, pp.285-293, 2018.

P. Sarode, M. B. Schaefer, F. Grimminger, W. Seeger, and R. Savai, Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk, Front. Oncol, vol.10, 2020.

M. S. Baig, A. Roy, S. Rajpoot, D. Liu, R. Savai et al., Tumor-derived exosomes in the regulation of macrophage polarization, Inflamm. Res, vol.69, pp.435-451, 2020.

Y. Hsu, J. Hung, W. Chang, S. Jian, Y. Lin et al., Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN, Mol. Ther, vol.26, pp.568-581, 2018.

S. Huang, Y. Li, J. Zhang, J. Rong, and S. Ye, Epidermal growth factor receptor-containing exosomes induce tumor-specific regulatory T cells. Cancer Investig, vol.31, pp.330-335, 2013.

Y. Yin, X. Cai, X. Chen, H. Liang, Y. Zhang et al., Tumor-secreted miR-214 induces regulatory T cells: A major link between immune evasion and tumor growth, Cell Res, vol.24, pp.1164-1180, 2014.

F. Chalmin, S. Ladoire, G. Mignot, J. Vincent, M. Bruchard et al., Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells, J. Clin. Investig, vol.120, pp.457-471, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00451697

D. H. Kim, H. Kim, Y. J. Choi, S. Y. Kim, J. Lee et al., Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer, Exp. Mol. Med, vol.51, pp.1-13, 2019.

G. Berchem, M. Z. Noman, M. Bosseler, J. Paggetti, S. Baconnais et al., Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-? and miR23a transfer

A. Clayton and Z. Tabi, Exosomes and the MICA-NKG2D system in cancer, Blood Cells Mol. Dis, vol.34, pp.206-213, 2005.

A. Clayton, S. Al-taei, J. Webber, M. D. Mason, and Z. Tabi, Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production, J. Immunol, vol.187, pp.676-683, 2011.

M. A. Rahman, J. F. Barger, F. Lovat, M. Gao, G. A. Otterson et al., Lung cancer exosomes as drivers of epithelial mesenchymal transition, Oncotarget, vol.7, pp.54852-54866, 2016.

A. Jouida, E. Crisetti, C. Mccarthy, A. Fabre, K. Mcauley et al., Exosomes form EGFR-mutated adenocarcinoma induce tumour invasion, Eur. Respir. J, vol.54, 2019.

Z. Li, C. Zeng, Q. Nong, F. Long, J. Liu et al., Exosomal Leucine-Rich-Alpha2-Glycoprotein 1 Derived from Non-Small-Cell Lung Cancer Cells Promotes Angiogenesis via TGF-? Signal Pathway, Mol. Ther. Oncolytics, vol.14, pp.313-322, 2019.

B. Sandfeld-paulsen, K. R. Jakobsen, R. Baek, B. H. Folkersen, T. R. Rasmussen et al., Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer, J. Thorac. Oncol, vol.11, pp.1701-1710, 2016.

Y. Li, Y. Zhang, F. Qiu, and Z. Qiu, Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC, Electrophoresis, vol.32, 1976.

A. Clayton, J. P. Mitchell, J. Court, M. D. Mason, and Z. Tabi, Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2, Cancer Res, vol.67, pp.7458-7466, 2007.

D. W. Greening, H. Ji, M. Chen, B. W. Robinson, I. M. Dick et al., Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo, Sci. Rep, vol.6, p.32643, 2016.

Y. Hsu, J. Hung, W. Chang, Y. Lin, Y. Pan et al., Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1, vol.36, pp.4929-4942, 2017.

J. Kim, T. Y. Kim, M. S. Lee, J. Y. Mun, C. Ihm et al., Exosome cargo reflects TGF-?1-mediated epithelial-to-mesenchymal transition (EMT) status in A549 human lung adenocarcinoma cells, Biochem. Biophys. Res. Commun, vol.478, pp.643-648, 2016.

Y. Liu, F. Luo, B. Wang, H. Li, Y. Xu et al., STAT3-regulated exosomal miR-21 promotes angiogenesis and is involved in neoplastic processes of transformed human bronchial epithelial cells, Cancer Lett, vol.370, pp.125-135, 2016.

H. Cui, B. Seubert, E. Stahl, H. Dietz, U. Reuning et al., Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes, Oncogene, vol.34, pp.3640-3650, 2015.

Q. Liu, Z. Yu, S. Yuan, W. Xie, C. Li et al., Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer, Oncotarget, vol.8, pp.13048-13058, 2017.

S. Sun, H. Chen, C. Xu, Y. Zhang, Q. Zhang et al., Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN, Life Sci, vol.244, 2020.

X. Zhang, B. Sai, F. Wang, L. Wang, Y. Wang et al., Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT, Mol. Cancer, vol.18, pp.1-15, 2019.

R. Cazzoli, F. Buttitta, M. Di-nicola, S. Malatesta, A. Marchetti et al., MicroRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer, J. Thorac. Oncol, vol.8, pp.1156-1162, 2013.

J. Lin, Y. Wang, Y. Zou, X. Chen, B. Huang et al., Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia, Tumour Biol, 2016.

X. Qin, S. Yu, L. Zhou, M. Shi, Y. Hu et al., Cisplatin-Resistant Lung Cancer Cell & Ndash; Derived Exosomes Increase Cisplatin Resistance of Recipient Cells in Exosomal Mir-100 & Ndash; 5p-Dependent Manner, 2020.

Y. Ma, D. Yuwen, J. Chen, B. Zheng, J. Gao et al., Exosomal Transfer of Cisplatin-Induced MiR-425-3p Confers Cisplatin Resistance in NSCLC Through Activating Autophagy, 2020.

C. Jing, H. Cao, X. Qin, S. Yu, J. Wu et al., Exosome-mediated gefitinib resistance in lung cancer HCC827 cells via delivery of miR-21, Oncol. Lett, vol.15, pp.9811-9817, 2018.

Y. Zhang, M. Li, and C. Hu, Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer, Biochem. Biophys. Res. Commun, vol.507, pp.457-464, 2018.

S. He, Z. Li, Y. Yu, Q. Zeng, Y. Cheng et al., Exosomal miR-499a-5p promotes cell proliferation, migration and EMT via mTOR signaling pathway in lung adenocarcinoma, Exp. Cell Res, vol.379, pp.203-213, 2019.

H. Fang, Y. Liu, Y. He, Y. Jiang, Y. Wei et al., Extracellular vesicle-delivered miR-505-5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1, Int. J. Oncol, vol.54, pp.1821-1832, 2019.

Y. Qi, W. Zha, and W. Zhang, Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer, J. BUON, vol.24, pp.599-607, 2019.

G. Rabinowits, C. Gerçel-taylor, J. M. Day, D. D. Taylor, and G. H. Kloecker, Exosomal microRNA: A diagnostic marker for lung cancer, Clin. Lung Cancer, vol.10, pp.42-46, 2009.

M. Rodríguez, J. Silva, A. López-alfonso, M. B. López-muñiz, C. Peña et al., Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer, Genes Chromosomes Cancer, vol.53, pp.713-724, 2014.

B. Roman-canal, C. P. Moiola, S. Gatius, S. Bonnin, M. Ruiz-miró et al., EV-associated miRNAs from pleural lavage as potential diagnostic biomarkers in lung cancer, Sci. Rep, vol.9, 2019.

Y. Zhang, Y. Zhang, Y. Yin, and S. Li, Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients, Pathol. Res. Pract, vol.215, 2019.

X. Jin, Y. Chen, H. Chen, S. Fei, D. Chen et al., Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing, Clin. Cancer Res, vol.23, pp.5311-5319, 2017.

J. Silva, V. García, Á. Zaballos, M. Provencio, L. Lombardía et al., Vesicle-related microRNAs in plasma of nonsmall cell lung cancer patients and correlation with survival, Eur. Respir. J, vol.37, pp.617-623, 2011.

Y. Zhang and H. Xu, Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients, J. Clin. Lab. Anal, vol.2020, 23237.

H. Dejima, H. Iinuma, R. Kanaoka, N. Matsutani, and M. Kawamura, Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer, Oncol. Lett, vol.13, pp.1256-1263, 2017.

T. Shukuya, V. Ghai, J. M. Amann, T. Okimoto, K. Shilo et al., Circulating miRNAs and extracellular vesicle containing miRNAs as response biomarkers of anti PD-1/PD-L1 therapy in non-small-cell lung cancer, J. Thorac. Oncol, 2020.

D. Yuwen, B. Sheng, J. Liu, W. Wenyu, and Y. Shu, MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci, vol.21, pp.2650-2658, 2017.

M. Giallombardo, J. Chacartegui, P. Reclusa, J. P. Van-meerbeeck, R. Alessandro et al., Follow up analysis by exosomal miRNAs in EGFR mutated non-small cell lung cancer (NSCLC) patients during osimertinib (AZD9291) treatment: A potential prognostic biomarker tool, vol.34, 2016.

P. B. Munson, E. M. Hall, N. H. Farina, H. I. Pass, and A. Shukla, Exosomal miR-16-5p as a target for malignant mesothelioma, Sci. Rep, vol.9, 2019.

T. Cavalleri, L. Angelici, C. Favero, L. Dioni, C. Mensi et al., Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease, PLoS ONE, vol.12, 2017.

K. Rohlenova, J. Goveia, M. García-caballero, A. Subramanian, J. Kalucka et al., Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis, Cell Metab, vol.31, pp.862-877, 2020.

M. Cao, M. Seike, C. Soeno, H. Mizutani, K. Kitamura et al., MiR-23a regulates TGF-?-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells, Int. J. Oncol, vol.41, pp.869-875, 2012.

H. Wu, J. Zhou, S. Mei, D. Wu, Z. Mu et al., Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7, J. Cell. Mol. Med, vol.21, pp.1228-1236, 2017.

S. Paget, The distribution of secondary growths in cancer of the breast. 1889, Cancer Metastasis Rev, vol.8, pp.98-101, 1989.

H. H. Popper, Progression and metastasis of lung cancer, Cancer Metastasis Rev, vol.35, pp.75-91, 2016.

R. S. Finn, F. J. Brims, A. Gandhi, N. Olsen, A. W. Musk et al., Postmortem findings of malignant pleural mesothelioma: A two-center study of 318 patients, Chest, vol.142, pp.1267-1273, 2012.

Y. Liu, J. Fan, T. Xu, N. Ahmadinejad, K. Hess et al., Extracellular vesicle tetraspanin-8 level predicts distant metastasis in non-small cell lung cancer after concurrent chemoradiation

A. Hoshino, B. Costa-silva, T. Shen, G. Rodrigues, A. Hashimoto et al., Tumour exosome integrins determine organotropic metastasis, Nature, vol.527, pp.329-335, 2015.

E. Mammadova-bach, P. Zigrino, C. Brucker, C. Bourdon, M. Freund et al., Platelet integrin ?6?1 controls lung metastasis through direct binding to cancer cell-derived ADAM9, JCI Insight, vol.1, 2016.

B. H. Choi, Y. H. Quan, J. Rho, S. Hong, Y. Park et al., Levels of Extracellular Vesicles in Pulmonary and Peripheral Blood Correlate with Stages of Lung Cancer Patients, World J. Surg, 2020.

Q. Liu, Y. Xiang, S. Yuan, W. Xie, C. Li et al., Plasma exosome levels in non-small-cell lung cancer: Correlation with clinicopathological features and prognostic implications, Cancer Biomark, vol.22, pp.267-274, 2018.

Q. Sabbagh, G. Andre-gregoire, L. Guevel, J. Gavard, and . Vesiclemia, Counting on extracellular vesicles for glioblastoma patients, Oncogene, vol.2020, pp.1-10
URL : https://hal.archives-ouvertes.fr/inserm-02915935

D. J. Clark, W. E. Fondrie, A. Yang, and L. Mao, Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes, J. Proteom, vol.133, pp.161-169, 2016.

B. Sandfeld-paulsen, N. Aggerholm-pedersen, R. Baek, K. R. Jakobsen, P. Meldgaard et al., Exosomal proteins as prognostic biomarkers in non-small cell lung cancer, Mol. Oncol, vol.10, pp.1595-1602, 2016.

N. Yanaihara, N. Caplen, E. Bowman, M. Seike, K. Kumamoto et al., Unique microRNA molecular profiles in lung cancer diagnosis and prognosis, Cancer Cell, vol.9, pp.189-198, 2006.

J. J. Castellano, R. M. Marrades, L. Molins, N. Viñolas, J. Moises et al., Extracellular Vesicle lincRNA-p21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior, Cancers

Y. Lei, W. Guo, B. Chen, L. Chen, J. Gong et al., Tumor-released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non-small cell lung cancer, Oncol. Rep, vol.40, pp.3438-3446, 2018.

N. Dilsiz, Role of exosomes and exosomal microRNAs in cancer, Future Sci, vol.2020

A. Thind and C. Wilson, Exosomal miRNAs as cancer biomarkers and therapeutic targets, J. Extracell. Vesicles, vol.5, p.31292, 2016.

M. F. Bolukbasi, A. Mizrak, G. B. Ozdener, S. Madlener, T. Ströbel et al., MiR-1289 and "Zipcode"-Like Sequence Enrich mRNAs in Microvesicles, Mol. Ther. Nucleic Acids, vol.1, 2012.

A. M. Marleau, C. Chen, J. A. Joyce, and R. H. Tullis, Exosome removal as a therapeutic adjuvant in cancer, J. Transl. Med, vol.10, 2012.

M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio et al., MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response, Proc. Natl. Acad. Sci, vol.109, pp.2110-2116, 2012.

A. Matsumoto, Y. Takahashi, M. Nishikawa, K. Sano, M. Morishita et al., Accelerated growth of B16BL6 tumor in mice through efficient uptake of their own exosomes by B16BL6 cells, Cancer Sci, vol.108, pp.1803-1810, 2017.

D. Jong, O. G. Van-balkom, B. W. Schiffelers, R. M. Bouten, C. V. Verhaar et al., Extracellular vesicles: Potential roles in regenerative medicine, Front. Immunol, vol.5, 2014.

T. Takenaka, S. Nakai, M. Katayama, M. Hirano, N. Ueno et al., Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells, Int. J. Pharm, vol.572, 2019.

M. S. Kim, M. J. Haney, Y. Zhao, V. Mahajan, I. Deygen et al., Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells, Nanomedicine, vol.12, pp.655-664, 2016.

I. L. Colao, R. Corteling, D. Bracewell, and I. Wall, Manufacturing Exosomes: A Promising Therapeutic Platform, Trends Mol. Med, vol.24, pp.242-256, 2018.

N. Del-piccolo, J. Placone, L. He, S. C. Agudelo, and K. Hristova, Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions, Anal. Chem, vol.84, pp.8650-8655, 2012.

H. Pick, E. L. Schmid, A. Tairi, E. Ilegems, R. Hovius et al., Investigating cellular signaling reactions in single attoliter vesicles, J. Am. Chem. Soc, vol.127, pp.2908-2912, 2005.

M. Mendt, S. Kamerkar, H. Sugimoto, K. M. Mcandrews, C. Wu et al., Generation and testing of clinical-grade exosomes for pancreatic cancer, JCI Insight, vol.3, 2018.

L. Battaglia and E. Ugazio, Lipid Nano-and Microparticles: An Overview of Patent-Related Research, 2020.

A. J. Vázquez-ríos, Á. Molina-crespo, B. L. Bouzo, R. López-lópez, G. Moreno-bueno et al., Exosome-mimetic nanoplatforms for targeted cancer drug delivery, J. Nanobiotechnol, vol.17, 2019.

Y. Tian, S. Li, J. Song, T. Ji, M. Zhu et al., A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy, Biomaterials, vol.35, pp.2383-2390, 2014.

A. C. Dingemans, . Van-den, V. Boogaart, B. A. Vosse, R. Van-suylen et al., Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer, Mol. Cancer, vol.9, p.152, 2010.

Y. Jhan, D. Prasca-chamorro, G. Palou-zuniga, D. M. Moore, . .;-arun et al., Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery, Int. J. Pharm, vol.573, p.118802, 2020.

N. Boisgerault, M. Grégoire, and J. Fonteneau, Viral cancer therapies: Are they ready for combination with other immunotherapies? Future Oncol, vol.13, pp.1569-1571, 2017.

L. Ran, X. Tan, Y. Li, H. Zhang, R. Ma et al., Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy, Biomaterials, vol.89, pp.56-66, 2016.

M. Garofalo, H. Saari, P. Somersalo, D. Crescenti, L. Kuryk et al., Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment, J. Control, vol.283, pp.223-234, 2018.

M. Garofalo, A. Villa, N. Rizzi, L. Kuryk, B. Rinner et al., Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice, J. Control. Release, vol.294, pp.165-175, 2019.

M. A. Morse, J. Garst, T. Osada, S. Khan, A. Hobeika et al., A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer, J. Transl. Med, vol.3, issue.9, 2005.

B. Besse, M. Charrier, V. Lapierre, E. Dansin, O. Lantz et al., Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
URL : https://hal.archives-ouvertes.fr/hal-01440237

M. Guo, F. Wu, G. Hu, L. Chen, J. Xu et al., Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion, Sci. Transl. Med, vol.11, 2019.